ribavirin has been researched along with Chemical Dependence in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.56) | 18.2507 |
| 2000's | 22 (56.41) | 29.6817 |
| 2010's | 15 (38.46) | 24.3611 |
| 2020's | 1 (2.56) | 2.80 |
| Authors | Studies |
|---|---|
| Kesić, S; Pešić, V; Petković, B | 1 |
| Amrose, P; Anand, S; Kumar, MS; McFall, AM; Mehta, SH; Ramasamy, B; Solomon, SS; Srikrishnan, AK; Sulkowski, MS; Thomas, DL | 1 |
| Bair, MJ; Chen, HL; Cheng, CH; Lee, YK; Lin, CC; Lin, IT; Wu, CH | 1 |
| Amory, C; Gardenier, D; Weiss, JJ; Woody, A | 1 |
| Bruggmann, P; Brunner, N; Falcato, L; Rosemann, T; Senn, O | 1 |
| Beckstead, S; Beking, D; Finch, S; Knorr, T; Lynch, C; MacKenzie, M; Mayer, D; Melles, B; Newman, AI; Shore, R | 1 |
| Basevitz, A; Levit, S; Malnick, S; Sheidvasser, V | 1 |
| Crawford, V; Dalton, J; Foster, GR; Hekker, M; Jolly, F; Marley, R; Sims, E; Tippet, A; Turton, J; Wilkinson, M | 1 |
| Daiter, J; John-Baptiste, A; Krahn, M; Lingley, M; Nedd-Roderique, T; Teplin, D; Tomlinson, G; Varenbut, M | 1 |
| Freedman, K; Nathanson, J | 1 |
| Dore, GJ; French, R; Grebely, J; Haber, PS; Hellard, M; Kaldor, JM; Lloyd, AR; Marks, P; Matthews, GV; McCaughan, G; Petoumenos, K; Rawlinson, W; van Beek, I; White, P; Yeung, B | 1 |
| Cacoub, P; Chousterman, M; Fontanges, T; Lang, JP; Marcellin, P; Melin, P; Ouzan, D; Rotily, M | 1 |
| Conway, B; DeVlaming, S; Duncan, F; Elliott, D; Gallagher, L; Genoway, KA; Grebely, J; Khara, M; Knight, E; Raffa, JD; Storms, M; Viljoen, M | 1 |
| Casteelen, G; Coutinho, RA; Jansen, PL; Krol, A; Lambers, FA; Lindenburg, CE; Prins, M; Schinkel, J; Urbanus, AT; van den Berg, CH; van Santen, G; Weegink, CJ | 1 |
| Albrecht, JK; Bloomer, JR; Boparai, N; Brass, CA; Brown, KA; Galler, GW; Ghalib, RH; Herrine, SK; Jiang, R; King, JW; McCone, J; McHutchison, JG; Melia, MT; Muir, AJ; Mullen, KD; Noviello, S; Nunes, FA; Ravendhran, N; Shiffman, ML; Sulkowski, MS | 1 |
| Foster, GR; Goldberg, DJ; Hickman, M; Hutchinson, SJ; Martin, NK; Miners, A; Vickerman, P | 1 |
| Arnsten, JH; Berg, KM; Hidalgo, J; Li, X; Litwin, AH | 1 |
| Charlebois, A; Cooper, E; Lee, L; Mason, K; Powis, J | 1 |
| Boonstra, A; de Knegt, RJ; Groothuismink, ZM; Hotho, DM; Janssen, HL; Kreefft, K | 1 |
| Lucidarme, D | 1 |
| Benhamou, Y; Bernard, B; Di Martino, V; Moussalli, J; Myers, RP; Poynard, T; Ratziu, V; Regimbeau, C; Thabut, D | 1 |
| Dhumeaux, D; Lerebours, E; Marcellin, P | 1 |
| Folwaczny, C; Grunze, H; Heldwein, W; Koenig, A; Loeschke, K; Lorenz, R; Martin, G; Schaefer, M; Schindlbeck, N; Schmidt, F; Soyka, M | 1 |
| Allen, S; Jacobs, G; Mitty, J; Schwartzapfel, B; Taylor, LE | 1 |
| Berger, F; Goelz, J; Jacob, B; Mauss, S; Schmutz, G | 1 |
| Backmund, M; Heinz, A; Schaefer, M | 1 |
| Borisov, AS; Broadwell, SD; Capuron, L; Jacobson, IM; Manatunga, AK; Miller, AH; Nemeroff, CB; Raison, CL; Woolwine, BJ | 1 |
| Baldelli, F; Canovari, B; Conte, ME; Di Candilo, F; Francisci, D; Sfara, C; Stagni, G; Valente, M | 1 |
| Barry, K; Cleare, AJ; Hotopf, M; Landau, S; Maddock, C; Maulayah, P; Norris, S; Pariante, CM | 1 |
| Ahmad, J; Anand, BS; Awad, J; Aytaman, A; Bini, EJ; Bräu, N; Chang, KM; Cheung, R; Currie, S; Hagedorn, C; Ho, SB; Hu, KQ; Jeffers, L; Johnson, D; King, P; Mendenhall, C; Morgan, TR; Moseley, R; Pedrosa, M; Rossi, S; Sasaki, AW; Schmidt, WN; Shen, H; Simon, F; Strader, D; Waters, B; Wright, TL | 1 |
| Amick, C; Andalkar, A; Bica, I; Bradley, M; Drewniak, S; Fiore, J; Galvin, S; Libone, G; McGovern, B; Molinaro-Gudas, V; Ramsey, J; Scheft, H; Taglienti, P; Wurcel, A | 1 |
| Gholam, PM; Rich, JD; Schwartzapfel, B; Taylor, LE | 1 |
| Hauser, P; Loftis, JM; Matthews, AM | 1 |
| Hauser, P; Loftis, JM; Rifai, MA | 1 |
| Clements, BJ; Malibu, Y; Sylvestre, DL | 1 |
| Sherman, KE | 1 |
| Berg, T; Friebe, A; Gutsche, J; Halangk, J; Heinz, A; Hinzpeter, A; Janssen, G; Kluschke, M; Mohmand, A; Pich, M; Sarkar, R; Schaefer, M; Schwaiger, M; Weich, V; Ziemer, M | 1 |
9 review(s) available for ribavirin and Chemical Dependence
| Article | Year |
|---|---|
Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder.
Topics: Adenosine; Amphetamine; Animals; Brain; Brain Chemistry; Central Nervous System Stimulants; Humans; Receptors, Dopamine D1; Ribavirin; Substance-Related Disorders | 2020 |
Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance use disorders.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Interferons; Mental Disorders; Polyethylene Glycols; Ribavirin; Substance-Related Disorders; Treatment Outcome | 2009 |
[Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
Topics: Adult; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Follow-Up Studies; France; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Heroin Dependence; Humans; Interferons; Prevalence; Prisons; Prognosis; Prospective Studies; Recurrence; Ribavirin; Risk Factors; Substance Abuse, Intravenous; Substance-Related Disorders; Time Factors | 2002 |
[What are the indications for treatment of acute hepatitis C?].
Topics: Acute Disease; Adult; Antiviral Agents; Clinical Enzyme Tests; Clinical Trials as Topic; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Interferon alpha-2; Interferon-alpha; Interferon-beta; Male; Meta-Analysis as Topic; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Risk Factors; Substance-Related Disorders; Time Factors; Transaminases; Transfusion Reaction | 2002 |
Consensus conference. Treatment of hepatitis C.
Topics: Adult; Aged; Alcoholism; Amantadine; Antiviral Agents; Body Weight; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Graft Rejection; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver Cirrhosis; Liver Transplantation; Male; Mental Disorders; Middle Aged; Monitoring, Physiologic; Quality of Life; Recurrence; Ribavirin; Risk Factors; Substance-Related Disorders; Time Factors | 2002 |
Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?
Topics: Antiviral Agents; Clinical Trials as Topic; Contraindications; Drug Therapy, Combination; Hepatitis C, Chronic; Heroin Dependence; Humans; Interferon-alpha; Mental Disorders; Research Design; Ribavirin; Substance-Related Disorders | 2004 |
Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management.
Topics: Antiviral Agents; Comorbidity; Hepatitis C, Chronic; Humans; Interferons; Mental Disorders; Ribavirin; Substance-Related Disorders | 2006 |
New paradigms in the management of hepatitis C virus co-infections.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Interactions; Drug Therapy, Combination; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance-Related Disorders; Virus Replication | 2007 |
[International consensus conference on hepatitis C. Conclusions. Organized under the auspices of the European Association for the Study of the Liver (EASL)].
Topics: Adult; Age Factors; Aged; AIDS-Related Opportunistic Infections; Alcoholism; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; Diagnosis, Differential; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Transplantation; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Substance-Related Disorders; Viral Hepatitis Vaccines | 1999 |
7 trial(s) available for ribavirin and Chemical Dependence
| Article | Year |
|---|---|
Directly observed therapy of sofosbuvir/ribavirin +/- peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Directly Observed Therapy; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; India; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Sofosbuvir; Substance-Related Disorders; Sustained Virologic Response; Treatment Outcome; Viral Load; Young Adult | 2018 |
Treatment of chronic hepatitis C infection among current and former injection drug users within a multidisciplinary treatment model at a community health centre.
Topics: Adult; Aged; Antiviral Agents; Community Health Centers; Community Health Services; Delivery of Health Care; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Ontario; Patient Care Team; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Substance-Related Disorders; Treatment Outcome; Young Adult | 2013 |
Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics.
Topics: Adult; Antiviral Agents; Directly Observed Therapy; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon-alpha; Male; Medication Adherence; Methadone; Middle Aged; Opiate Substitution Treatment; Polyethylene Glycols; Recombinant Proteins; Research Design; Ribavirin; Substance-Related Disorders; Treatment Outcome | 2011 |
A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Methadone; Middle Aged; Narcotics; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Substance-Related Disorders; Treatment Outcome | 2004 |
Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response.
Topics: Adult; Antiviral Agents; Anxiety; Depression; Drug Carriers; Drug Therapy, Combination; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Severity of Illness Index; Substance-Related Disorders; Time Factors; Treatment Outcome | 2005 |
Cannabis use improves retention and virological outcomes in patients treated for hepatitis C.
Topics: Adolescent; Adult; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Marijuana Smoking; Middle Aged; Patient Compliance; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Substance-Related Disorders; Treatment Outcome; Viral Load | 2006 |
Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.
Topics: Adult; Antidepressive Agents; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Mental Disorders; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors; Substance-Related Disorders; Treatment Outcome | 2007 |
23 other study(ies) available for ribavirin and Chemical Dependence
| Article | Year |
|---|---|
Genotype distribution and treatment response among incarcerated drug-dependent patients with chronic hepatitis C infection.
Topics: Adult; Antiviral Agents; Case-Control Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Prisoners; Ribavirin; Substance-Related Disorders | 2018 |
Interprofessional team-based approach to patients with chronic hepatitis C and personality disorder: Three case studies.
Topics: Adult; Anemia; Antiviral Agents; Comorbidity; Delivery of Health Care, Integrated; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Interprofessional Relations; Male; Middle Aged; Personality Disorders; Polyethylene Glycols; Primary Health Care; Recombinant Proteins; Ribavirin; Sofosbuvir; Substance-Related Disorders | 2019 |
Hepatitis C treatment for multimorbid patients with substance use disorder in a primary care-based integrated treatment centre: a retrospective analysis.
Topics: Adult; Antiviral Agents; Delivery of Health Care, Integrated; Drug Administration Schedule; Drug Therapy, Combination; Feasibility Studies; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Opiate Substitution Treatment; Primary Health Care; Recombinant Proteins; Retrospective Studies; Ribavirin; Socioeconomic Factors; Substance-Related Disorders; Switzerland; Treatment Failure; Treatment Outcome | 2013 |
A model for treating HCV hepatitis in patients receiving methadone maintenance therapy.
Topics: Adult; Antiviral Agents; Comorbidity; Hepatitis C; Humans; Interferon-alpha; Methadone; Narcotics; Opiate Substitution Treatment; Ribavirin; Substance-Related Disorders | 2014 |
Community-based treatment for chronic hepatitis C in drug users: high rates of compliance with therapy despite ongoing drug use.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Drug Users; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Patient Compliance; Ribavirin; Substance-Related Disorders; Treatment Outcome; Viral Load | 2009 |
Treatment of hepatitis C infection for current or former substance abusers in a community setting.
Topics: Adult; Antiviral Agents; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Methadone; Middle Aged; Patient Compliance; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance-Related Disorders; Treatment Outcome | 2009 |
Effective treatment of injecting drug users with recently acquired hepatitis C virus infection.
Topics: Acute Disease; Adult; Antiviral Agents; Australia; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Ribavirin; RNA, Viral; Seroepidemiologic Studies; Substance-Related Disorders; Treatment Outcome | 2010 |
Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study.
Topics: Analgesics, Opioid; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Hepatitis C, Chronic; Interferon alpha-2; Interferon-alpha; Medication Adherence; Polyethylene Glycols; Prospective Studies; Quality of Life; Recombinant Proteins; Ribavirin; Substance-Related Disorders; Surveys and Questionnaires; Treatment Outcome | 2010 |
Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support.
Topics: Adult; Antiviral Agents; Drug Carriers; Female; Hepatitis C; Hepatitis C Antibodies; Humans; Interdisciplinary Communication; Interferons; Male; Medical Records; Middle Aged; Odds Ratio; Patient Care Team; Peer Group; Polyethylene Glycols; Retrospective Studies; Ribavirin; Self-Help Groups; Substance-Related Disorders; Treatment Outcome | 2010 |
Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project.
Topics: Adult; Antibodies, Viral; Antiviral Agents; Cohort Studies; Comorbidity; Drug Users; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Netherlands; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Substance-Related Disorders; Treatment Outcome | 2011 |
Racial differences in hepatitis C treatment eligibility.
Topics: Adult; Alcoholism; Antiviral Agents; Black People; Diabetes Complications; Eligibility Determination; Female; Heart Diseases; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Mass Screening; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Retrospective Studies; Ribavirin; Substance-Related Disorders; Treatment Outcome; United States; White People | 2011 |
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations.
Topics: Antiviral Agents; Cost-Benefit Analysis; Drug Costs; Hepatitis C, Chronic; Humans; Injections, Intravenous; Interferon-alpha; Needles; Polyethylene Glycols; Prevalence; Ribavirin; Risk Factors; Secondary Prevention; Substance-Related Disorders; Syringes; United Kingdom | 2012 |
Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients.
Topics: Adult; Antiviral Agents; Cohort Studies; Female; Health Services Accessibility; Hepatitis A Vaccines; Hepatitis B Vaccines; Hepatitis C; Humans; Interferons; Male; Middle Aged; Patient Acceptance of Health Care; Retrospective Studies; Ribavirin; Self-Help Groups; Social Marginalization; Substance-Related Disorders; Treatment Outcome; Viral Load | 2012 |
Natural killer cell activity and function in chronic HCV-infected patients during peg interferon and ribavirin: early effects of active substance use.
Topics: Adult; Drug Users; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Killer Cells, Natural; Male; Middle Aged; Ribavirin; Substance-Related Disorders | 2013 |
[Treatment of hepatitis C: advances and consensus].
Topics: Aged; Alcoholism; Antiviral Agents; Carcinoma, Hepatocellular; Consensus Development Conferences as Topic; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferons; Liver Cirrhosis; Male; Paris; Research; Ribavirin; Risk Factors; Substance-Related Disorders | 2002 |
Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
Topics: Adult; Alcohol Drinking; Antidepressive Agents; Antiviral Agents; Depression; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Medical Records; Mental Disorders; Methadone; Middle Aged; Patient Compliance; Patient Dropouts; Prospective Studies; Ribavirin; Risk Factors; Substance-Related Disorders | 2003 |
Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence.
Topics: Anti-HIV Agents; Antiviral Agents; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Mental Disorders; Ribavirin; Substance-Related Disorders; Treatment Refusal; Viral Load | 2003 |
Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C.
Topics: Adult; Antiviral Agents; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Statistics, Nonparametric; Substance-Related Disorders; Treatment Failure; Treatment Outcome; Viral Load | 2005 |
[Epidemiological, clinical and therapeutical aspects of HIV/HCV coinfection in a series of HIV seropositive Umbrian patients].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Biopsy; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Italy; Liver; Male; Patient Compliance; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Substance-Related Disorders; Treatment Outcome | 2004 |
Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.
Topics: Antiviral Agents; Contraindications; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Mental Disorders; Middle Aged; Patient Acceptance of Health Care; Patient Selection; Ribavirin; Substance-Related Disorders; Treatment Outcome; United States; Veterans | 2005 |
Delivering therapy for hepatitis C virus infection to incarcerated HIV-seropositive patients.
Topics: Demography; Drug Interactions; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Liver; Male; Prisoners; Ribavirin; Substance-Related Disorders; Treatment Outcome | 2005 |
Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report.
Topics: Adult; Antiviral Agents; Depression; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance-Related Disorders; Treatment Outcome | 2005 |
Hepatitis C treatment of veterans with psychiatric illness.
Topics: Antiviral Agents; Cohort Studies; Comorbidity; Contraindications; Dementia; Hepatitis C, Chronic; Humans; Interferon-alpha; Mental Disorders; Prejudice; Ribavirin; Risk Factors; Substance-Related Disorders; Veterans | 2006 |